Further data demonstrated that the knockdown of TGF-β1 in MSCs inhibited stroma-induced ALDH activity in cancer cells, while on the other hand, the treatment with recombinant TGF-β1 induced ALDH activity in cancer cells. Here, LDHA is linked to cancer.